| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5285226
Max Phase: Preclinical
Molecular Formula: C28H44N4O4
Molecular Weight: 500.68
Associated Items:
Representations
Canonical SMILES: CCOC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@]12C)[C@@]1(C)CC[C@@H](OC(C)=O)C[C@H]1Cc1nnnn13
Standard InChI: InChI=1S/C28H44N4O4/c1-6-35-25(34)10-7-17(2)21-8-9-22-26-23(12-14-28(21,22)5)27(4)13-11-20(36-18(3)33)15-19(27)16-24-29-30-31-32(24)26/h17,19-23,26H,6-16H2,1-5H3/t17-,19+,20-,21-,22+,23+,26+,27+,28-/m1/s1
Standard InChI Key: FVRDBNZMKRPGQR-IKLFMUROSA-N
Associated Targets(Human)
Aldo-keto-reductase family 1 member C3 1414 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 500.68 | Molecular Weight (Monoisotopic): 500.3363 | AlogP: 4.93 | #Rotatable Bonds: 6 |
| Polar Surface Area: 96.20 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.25 | CX LogD: 4.25 |
| Aromatic Rings: 1 | Heavy Atoms: 36 | QED Weighted: 0.51 | Np Likeness Score: 0.96 |
References
| 1. Marinović MA, Bekić SS, Kugler M, Brynda J, Škerlová J, Škorić DĐ, Řezáčová P, Petri ET, Ćelić AS.. (2023) X-ray structure of human aldo-keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis., 14 (2.0): [PMID:36846371] [10.1039/d2md00387b] |
Source
Source(1):